Drugs Made In America Acquisition Corp. (DMAA)
Nasdaq · Financial Services · Shell Companies
$10.890.00%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $264M
- P/E (trailing)
- 60.5
- 52-week range
- $10.26 – $10.89
- 52-week change
- +5.76%
- EPS (trailing)
- $0.18
Fiscal year to Dec 2025
- Net income
- $5.9M
From the company’s annual report on SEC EDGAR.
About Drugs Made In America Acquisition Corp.
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
Headquarters: New York, United States